Compare SGMO & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGMO | TSE |
|---|---|---|
| Founded | 1995 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.1M | 68.0M |
| IPO Year | 2000 | 2014 |
| Metric | SGMO | TSE |
|---|---|---|
| Price | $0.44 | $0.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | ★ $4.71 | $1.00 |
| AVG Volume (30 Days) | ★ 6.1M | 826.3K |
| Earning Date | 11-06-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 6.22% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $32,875,000.00 | ★ $3,133,800,000.00 |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $0.46 |
| 52 Week High | $2.73 | $5.99 |
| Indicator | SGMO | TSE |
|---|---|---|
| Relative Strength Index (RSI) | 43.82 | 25.92 |
| Support Level | $0.43 | $0.46 |
| Resistance Level | $0.49 | $0.52 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 10.29 | 4.76 |
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.